Editors and the publisher of Journal of Information Systems Engineering and Management believe that ethical guidelines should be respected in the publishing of the journal. With these guidelines, the quality of the journal can be guaranteed. Science needs to be reliable and based on the right resources. To prevent articles from being unrightly duplicated or being subject to any other misconduct, every party involved in the publishing has to behave according to the ethical guidelines.
Conflicts of interest
Reliability of the articles is important, and thus any conflict of interest on the side of the author, peer-reviewer or the editors should be avoided. These conflicts of interest can be on the personal, financial, political, academic or religious level. Authors, peer-reviewers or editors should, whenever these are relevant to the content being considered or published, declare their interests and affiliations, so that the appropriate measures can be taken by the editorial board. If needed, a statement can be made in the journal that a certain person has a personal, financial, political, academic or religious conflict of interest with the topic.
One of the measures that the editorial board can take when there is a conflict in interests is to change the persons who are involved in peer-reviewing the article. Authors can also be prevented to publish their article in the journals. The existence of a conflict of interest should however not prevent someone of being included in the list of authors, if they qualify for authorship.
Readers should know who funded the research project or the publication of a document. This can be a charity or government department, university or commercial company. And so:
-Funders of a paper, in the form of persons, organizations or companies or any other form should be mentioned.
-The role of the research funders or any other research contributors in the design or preparation of the article should be mentioned, if they are not mentioned in the list of authors. They can, for example, be mentioned in acknowledgment.
-If a funder wants to publish a supplement or separate section in the journal, they should ask for permission of Lectito Journals. Applications will be handled case by case.
-Contributors and their sources have to be properly acknowledged in the article according to guidelines. Guidelines on notes and references can be found under the submission guidelines of the journal.
-Authors of research papers should state whether they had complete access to the research data that support the article and if not, they should state this in the article.
-Authors and contributors should have approved the acknowledgment of their contribution.
-When the article is written by a group of authors, the individual authors who have direct responsibility for the manuscript should be mentioned. When a group author manuscript is submitted, the corresponding author should indicate the preferred citation of the group name as well the names of the individual authors.
It is important that authors and peer-reviewers handle the information carefully and that informants and research subjects are protected.
-Authors should provide a statement in which they identify the ethics committee that approved that the study conforms to recognized standards. These standards ensure the reader that adequate steps have been taken to minimize physical and psychological harm to participants and to avoid coercion or exploitation. Across the scholarly disciplines, there are variations in practice and standards around privacy and confidentiality. Authors should strive to treat the privacy of research objects with as much care as possible. Where there is no consent of the individual that appears in a picture, the person should be made anonymous.
Authors should be careful in publishing images of objects that might have cultural significance and cause offense (as in for example religious texts). JISEM has the right to refuse articles that may cause offense or violations of human dignity.
-JISEM requires that authors who discuss a clinical trial, demonstrate that the clinical trial is registered in a publicly accessible database. Authors should include the name of the trial register and their clinical trial registration number at the end of their abstract. If you wish the editor[s] to consider an unregistered trial, please explain briefly why the trial has not been registered.